New stent aims to prevent uterine scarring in women

NCT ID NCT07611474

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a new uterine stent to prevent intrauterine adhesions (scar tissue) after surgery in women aged 20-40. 200 participants will be randomly assigned to receive either the new stent or standard care (uterine ring, balloon, and gel). The goal is to see if the stent reduces scarring and is safe to use.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
uterine stent (device)
What this could lead to
If it works, this could offer a simpler, safer way to prevent scar tissue in the uterus after surgery, helping preserve fertility.
What could go wrong
This is an early-stage trial with only 200 participants, so results may not apply to everyone. The device might not work better than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAUTERINE ADHESION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Third Xiangya Hospital of Central South University

    RECRUITING

    Changsha, Hunan, 410013, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.